The results not only clarify detailed clinical findings such as long-term growth and maturation patterns including the effects of GH and GnRHa therapies and the details of psychomotor developmental delay and metabolic complications as well as adulthood phenotype but also provide useful implications for the diagnosis and management of TS14 patients. This evidence concerns the gene GH1 and Global developmental delay.